Efficacy and adverse events of oral isotretinoin for acne: a systematic review
- PMID:28542914
- DOI: 10.1111/bjd.15668
Efficacy and adverse events of oral isotretinoin for acne: a systematic review
Abstract
Despite many years of clinical use of isotretinoin, a comprehensive review of evidence for isotretinoin therapy in patients with acne is lacking. We searched MEDLINE, Embase, Cochrane Central, relevant web pages and bibliographies for randomized controlled trials in acne evaluating isotretinoin vs. control (placebo or other therapy). Data were extracted and summarized descriptively. Eleven trials were identified (total 760 patients randomized), containing mostly men. Mean treatment ages ranged from 18 to 47·9 years and participants generally had moderate-to-severe acne. Across all trials, isotretinoin therapy reduced acne lesion counts by a clinically relevant amount, and always by a greater amount than control, which was either placebo (two studies), oral antibiotics (seven studies) or other control (two studies). Across trials with an overall low risk of bias, two of three demonstrated statistically significant differences between isotretinoin and control. The frequency of adverse events was twice as high with isotretinoin (751 events) than with control (388 events). More than half of all adverse events were dermatological and related to dryness. Adverse events from isotretinoin causing participant withdrawal from trials (12 patients) included Stevens-Johnson syndrome, cheilitis, xerosis, acne flare, photophobia, elevated liver enzymes, decreased appetite, headaches and depressed mood. This review suggests that isotretinoin is effective in reducing acne lesion counts, but adverse events are common. This study was registered with PROSPERO number CRD42015025080.
© 2017 British Association of Dermatologists.
Similar articles
- Oral isotretinoin for acne.Costa CS, Bagatin E, Martimbianco ALC, da Silva EM, Lúcio MM, Magin P, Riera R.Costa CS, et al.Cochrane Database Syst Rev. 2018 Nov 24;11(11):CD009435. doi: 10.1002/14651858.CD009435.pub2.Cochrane Database Syst Rev. 2018.PMID:30484286Free PMC article.
- High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.Blasiak RC, Stamey CR, Burkhart CN, Lugo-Somolinos A, Morrell DS.Blasiak RC, et al.JAMA Dermatol. 2013 Dec;149(12):1392-8. doi: 10.1001/jamadermatol.2013.6746.JAMA Dermatol. 2013.PMID:24173086
- Effectiveness Of Oral Omega 3 In Reducing Mucocutaneous Side Effects Of Oral Isotretinoin In Patients With Acne Vulgaris.Zainab Z, Malik NA, Obaid S, Malik S, Aftab K, Mumtaz M, Pervez A, Syed Z.Zainab Z, et al.J Ayub Med Coll Abbottabad. 2021 Jan-Mar;33(1):60-63.J Ayub Med Coll Abbottabad. 2021.PMID:33774956
- Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.Lee YH, Scharnitz TP, Muscat J, Chen A, Gupta-Elera G, Kirby JS.Lee YH, et al.JAMA Dermatol. 2016 Jan;152(1):35-44. doi: 10.1001/jamadermatol.2015.3091.JAMA Dermatol. 2016.PMID:26630323Review.
- The role of isotretinoin in acne therapy: why not as first-line therapy? facts and controversies.Rigopoulos D, Larios G, Katsambas AD.Rigopoulos D, et al.Clin Dermatol. 2010 Jan-Feb;28(1):24-30. doi: 10.1016/j.clindermatol.2009.03.005.Clin Dermatol. 2010.PMID:20082946Review.
Cited by
- Common Non-Rheumatic Medical Conditions Mimicking Fibromyalgia: A Simple Framework for Differential Diagnosis.D'Amuri A, Greco S, Pagani M, Presciuttini B, Ciaffi J, Ursini F.D'Amuri A, et al.Diagnostics (Basel). 2024 Aug 13;14(16):1758. doi: 10.3390/diagnostics14161758.Diagnostics (Basel). 2024.PMID:39202246Free PMC article.Review.
- Acne Vulgaris: A Patient and Physician's Experience.Espinosa NI, Cohen PR.Espinosa NI, et al.Dermatol Ther (Heidelb). 2020 Feb;10(1):1-14. doi: 10.1007/s13555-019-00335-0. Epub 2019 Nov 7.Dermatol Ther (Heidelb). 2020.PMID:31701473Free PMC article.
- The Safety of Isotretinoin Treatment in Patients with Peanut Allergies.Yildirim AM, Lemons N, Yousaf A, Zinn ZA.Yildirim AM, et al.J Clin Aesthet Dermatol. 2022 Dec;15(12):49-51.J Clin Aesthet Dermatol. 2022.PMID:36569531Free PMC article.
- Concomitant Therapy of Oral Isotretinoin with Multiplex Pulsed Dye Laser and Nd: YAG Laser for Acne.Sapra S, Lultschik SD, Tran JV, Dong K.Sapra S, et al.J Clin Aesthet Dermatol. 2022 Sep;15(9):20-24.J Clin Aesthet Dermatol. 2022.PMID:36213602Free PMC article.Review.
- Consensus on the use of oral isotretinoin in dermatology - Brazilian Society of Dermatology.Bagatin E, Costa CS, Rocha MADD, Picosse FR, Kamamoto CSL, Pirmez R, Ianhez M, Miot HA.Bagatin E, et al.An Bras Dermatol. 2020 Nov-Dec;95 Suppl 1(Suppl 1):19-38. doi: 10.1016/j.abd.2020.09.001. Epub 2020 Oct 3.An Bras Dermatol. 2020.PMID:33036809Free PMC article.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical